Cited by 112Gastrointestinal motility and disordersInflammatory Bowel DiseasePain Mechanisms and Treatments

Fecal proteases from diarrheic-IBS and ulcerative colitis patients exert opposite effect on visceral sensitivity in mice

Annaházi, Anita, Gecse, Krisztina, Dabek, Marta, Ait-Belgnaoui, Afifa, Rosztóczy, András, Róka, Richárd, Molnár, Tamás, Theodorou, Vassilia +3 more·2009·Pain

Abstract

Elevated colonic luminal serine-protease (Ser-P) activity of diarrhea-predominant IBS (IBS-D) patients evokes a proteinase-activated receptor (PAR)-2-mediated colonic hypersensitivity in mice. Despite similarly elevated Ser-P levels in feces, patients with IBD exhibit visceral hypo- or normosensitivity to rectal distension, as opposed to IBS-D. To explain these discrepancies we studied the effect of colonic infusion of fecal supernatants from ulcerative colitis (UC) patients to colorectal mechanical sensitivity of mice and explored the involvement of PAR-4 and its activator Cathepsin-G (Cat-G). Fecal protease activities were assayed in healthy subjects, IBS-D and UC patients in presence or not of antiproteases or Cat-G inhibitor. Following intracolonic infusion of fecal supernatants from healthy subjects, IBS-D and UC patients or PAR-4 activating peptide (PAR-4-AP) or Cat-G, EMG response to colorectal balloon distension was recorded in mice. This nociceptive response was also determined after treatment with pepducin (PAR-4 antagonist) on UC supernatant or after a preincubation with antiproteases or Cat-G inhibitor. In contrast to IBS-D supernatant, UC supernatant promoted colonic hyposensitivity to distension, an effect mimicked by PAR-4-AP or Cat-G. UC supernatant-induced hypoalgesia was inhibited by a cocktail of antiproteases. However, blockade of PAR-4 or Cat-G inhibition resulted in colonic hypersensitivity similar to that observed after IBS-D supernatant infusion. Despite similarly elevated Ser-P activities, IBS-D and UC fecal supernatant display visceral pro- and antinociceptive effects in mice, respectively. Visceral hyposensitivity induced by fecal supernatant from UC patients results from PAR-4 activation by cathepsin-G, counterbalancing the pronociceptive effect of simultaneous PAR-2 activation.

Integrity signals

Registry

Crossref · 10.1016/j.pain.2009.04.017

Cites

37 of 37 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Intracolonic administration of fecal supernatants from IBS-D and IBS-C patients increased the visceromotor response to distension, with evidence of both allodynia and hyperalgesia.

    “Intracolonic administration of fecal supernatants from IBS-D and IBS-C patients increased the visceromotor response to distension, with evidence of both allodynia and hyperalgesia.159,160”
  • Fecal supernatants from UC patients had the opposite effect, decreasing the visceromotor response in a PAR-4-dependent manner.

    “In contrast, fecal supernatants from UC patients had the opposite effect, decreasing the visceromotor response in a PAR-4-dependent manner.159”

Cites

1 retracted

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Annaházi, A., Gecse, K., Dabek, M., Ait-Belgnaoui, A., Rosztóczy, A., Róka, R., Molnár, T., Theodorou, V., Wittmann, T., Bueno, L., & Eutamene, H.
Affiliations
  • Institut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement (FR)
  • University of Szeged (HU)
Venue
Pain
Published
2009-07
Volume
144
Issue
1
Pages
209-217
ISSN
0304-3959 (ISSN-L)
OpenAlex
W1973233423
Cited by
112
References
37
Citations by year
2026: 2 · 2025: 4 · 2024: 4 · 2023: 8 · 2022: 8 · 2021: 11 · 2020: 3 · 2019: 7 · 2018: 6 · 2017: 5 · 2016: 11 · 2015: 6 · 2014: 7 · 2013: 8 · 2012: 7
FWCI
7.79
Type
journal article
Language
en
Open access
closed
Locations
  • Pain (publishedVersion)
  • PubMed (publishedVersion)
  • Data Archiving and Networked Services (DANS) (submittedVersion)
  • Pure Amsterdam UMC (submittedVersion)
Funders
Institut National de la Recherche Agronomique
Topics
  • Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Inflammatory Bowel Disease
  • Health Sciences › Medicine › Physiology › Pain Mechanisms and Treatments
Keywords
diarrhea-predominant irritable bowel syndrome, ulcerative colitis, visceral sensitivity, colonic hypersensitivity, proteinase-activated receptor 4, protease-activated receptor 2, cathepsin G, serine protease, colorectal distension, fecal supernatants, pepducins, inflammatory bowel disease
MeSH terms
Adult, Analysis of Variance, Animals, Colitis, Ulcerative, Enzyme Inhibitors, Feces, Female, Humans, Male, Mice, Inbred C57BL, Middle Aged, Perception, Sensory Thresholds, Serine Endopeptidases, Viscera, Irritable Bowel Syndrome, Receptors, Proteinase-Activated, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review